Ghods Ahad J
Transplantation Unit, Hasheminejad Kidney Center, Iran University of Medical Sciences, Tehran, Iran.
Iran J Kidney Dis. 2009 Oct;3(4):183-91.
During the past decades, the number of altruistic living unrelated kidney donations has substantially increased in developed countries. However, the altruistic supply of transplantable kidneys has remained much less than the demand. As a result, severe kidney shortage has been associated with increasing number of patient deaths and increasing number of commercial transplants and transplant tourism. Studies have shown that there is still a need for living kidney donation because even all potential brain-dead donors cannot supply the escalating need for kidneys. The use of living unrelated kidney donors should be morally and ethically justified and should be compatible with ethical principles. Many experts believe that increasing number of patient deaths and commercial transplants will continue to happen if kidney donation system remains merely altruistic. While some transplant professionals support a paid and regulated system to eliminate kidney shortage, others argue that it will be destructive. Iran has a 20-year experience with a compensated and regulated living unrelated kidney donation program. This transplantation model was adopted in 1988, and successfully eliminated kidney transplant waiting list by the end of 1999. Currently, more than 50% of patients with end-stage kidney disease in Iran are living with a functioning graft. This Iranian transplantation model has many ethical successes. However, because it has not been well regulated by transplant ethicists, some ethical shortcomings have remained. Unfortunately, due to lack of interest and expertise in health authorities, the number of serious ethical failures is also increasing in this transplantation model.
在过去几十年里,发达国家中利他性非亲属活体肾捐赠的数量大幅增加。然而,可用于移植的利他性肾脏供应仍远远低于需求。结果,严重的肾脏短缺导致患者死亡人数增加,商业移植和移植旅游数量也不断上升。研究表明,仍然需要活体肾捐赠,因为即使所有潜在的脑死亡捐赠者也无法满足不断增长的肾脏需求。使用非亲属活体肾捐赠者在道德和伦理上应是合理的,并且应符合伦理原则。许多专家认为,如果肾脏捐赠系统仅仅依靠利他性,患者死亡人数和商业移植数量将继续增加。虽然一些移植专业人士支持建立一个有偿且受监管的系统来消除肾脏短缺,但另一些人则认为这将具有破坏性。伊朗在有偿且受监管的非亲属活体肾捐赠项目方面有20年的经验。这种移植模式于1988年采用,并在1999年底成功消除了肾脏移植等待名单。目前,伊朗超过50%的终末期肾病患者依靠功能正常的移植肾生活。这种伊朗移植模式在伦理方面有许多成功之处。然而,由于移植伦理学家没有对其进行有效监管,仍存在一些伦理缺陷。不幸的是,由于卫生当局缺乏兴趣和专业知识,这种移植模式中严重伦理失误的数量也在增加。